Inpatient prescribing of dual antiplatelet therapy according to the guidelines: a prospective intervention study

• Egile Nagusiak: Ashwin R. Moerlie (Egilea), Renate C. van Uden (Egilea), Aukje K. Mantel (Egilea), Patricia van den Bemt (Egilea), Matthijs L. Becker (Egilea)
• Formatua: Liburua
• Argitaratua: Centro de Investigaciones y Publicaciones Farmaceuticas, 2020-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: In dual antiplatelet therapy (DAPT), low-dose acetylsalicylic acid is combined with a P2Y12 inhibitor. However, combining antithrombotic agents increases the risk of bleeding. Guidelines on DAPT recommend using this combination for a limited period of between three weeks and 30 months. T...